Our formulation expertise supports material science decisions, while our processing expertise guides customers to use the materials properly. WHAT WE DO: MATERIAL SCIENCE 5 CUSTOM FORMULATION FE BRUARY 1 5 , 2023 W EB CAS T Q4 2022 VS. Avient Specialty Other Specialty / 2023E(%) 31 79 87 81 79 76 73 90 77 76 75 73 64 59 33 MULTIPLE EXPANSION Avient Specialty Other Specialty / Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.